The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
FKONCO Key Metrics
FKONCO Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
FKONCO Share Price
FKONCO
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
FKONCO Stock Analysis
Views
Red Flags
Positive
Consistently pays dividend
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
FKONCO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
FKONCO Bulk, Block & Insider Trades
FKONCO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Fresenius Kabi Oncology Limited is an India-based company, which is engaged in manufacturing of generic pharmaceutical products. The Company develops, manufactures and markets anti-cancer products. Its segments include Formulation, Bulk Drug and R&D. Its products include active pharmaceutical ingred... Read More
Key personnel
Ms. Maria GobbiD
Non-Executive Chairman of the Board
Mr. Rahul Sharma
Chief Financial Officer
Mr. Arvind Kumar SharmaD
Managing Director, Director
Mr. Nikhil KulshreshthaD
Company Secretary, Director
Dr. Uday Chandrashekhar ShettyD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Fresenius Kabi Oncology Ltd?
The current share price of Fresenius Kabi Oncology Ltd is ₹ 132.50 as of 02 Jan 2014.
What is the PE ratio of Fresenius Kabi Oncology Ltd?
The Price-to-Earnings (PE) ratio of Fresenius Kabi Oncology Ltd is - as of the latest financial data.
What is the ROE and ROCE of Fresenius Kabi Oncology Ltd?
Fresenius Kabi Oncology Ltd has a Return on Equity (ROE) of 2.59% and a Return on Capital Employed (ROCE) of 0.02% as per the latest financial reports.
What is the market cap of Fresenius Kabi Oncology Ltd?
The market capitalization of Fresenius Kabi Oncology Ltd stands at -.
What is the dividend yield of Fresenius Kabi Oncology Ltd?
The dividend yield of Fresenius Kabi Oncology Ltd is 0.00% based on the current market price.
What is the RSI of Fresenius Kabi Oncology Ltd?
The Relative Strength Index (RSI) of Fresenius Kabi Oncology Ltd is 66.74.
What is the FII and DII holding in Fresenius Kabi Oncology Ltd?
Foreign Institutional Investors (FII) hold - and Domestic Institutional Investors (DII) hold - of Fresenius Kabi Oncology Ltd shares.
What sector does Fresenius Kabi Oncology Ltd belong to?
Fresenius Kabi Oncology Ltd operates in the Healthcare sector.
What is the beta of Fresenius Kabi Oncology Ltd stock?
The beta of Fresenius Kabi Oncology Ltd stock is 0.28, indicating its volatility relative to the broader market.
